Biopharma News

Oct 24, 2014
Celgene expands its oncology drug discovery and development portfolio through a new partnership with Sutro.
Oct 24, 2014
By BioPharm International Editors
Johnson& Johnson is collaborating with WHO and others on clinical testing, development, production, and distribution of an ebola vaccine.
Oct 24, 2014
Shire announces it will expand its orphan drug portfolio and is ready for future M&A discussions.
Oct 23, 2014
Secukinumab is the first IL-17A inhibitor to meet its primary endpoint in two Phase III trials for patients with ankylosing spondylitis.
Oct 22, 2014
The renovation to Roche's historic office building in Basel, Switzerland will feature sustainable workplaces and a state-of-the-art research center.
Oct 20, 2014
A Priority Review voucher Sanofi and Regeneron purchased from BioMarin pharmaceuticals may put their mAb ahead of Amgen's in the market.
Oct 20, 2014
By BioPharm International Editors
AbbVie to pay Shire $1.636 billion break fee for terminating purchase agreement.
Oct 17, 2014
By BioPharm International Editors
Lilly announces the closure of its Guayama, Puerto Rico manufacturing facility amid continued investments at other plants.
Oct 16, 2014
By BioPharm International Editors
Sanofi Pasteur and Immune Design agree to jointly develop therapies through Phase II clinical trials.
Oct 16, 2014
Pfizer's addition of a new vaccine suite and multiproduct bioprocess suite to its Ireland facility win the company the title of 2014 Facility of the Year.
native1_300x100
lorem ipsum